Magnesium Sulfate In Dextrose NDC 0338-1709

NDC codes

FDA NDC Directory

Product NDC (as listed)0338-1709Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00338-1709Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0338-1709-40	00338170940	40 BAG in 1 CASE (0338-1709-40) / 100 mL in 1 BAGMarketed from Aug 11, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Magnesium Sulfate In Dextrose
Generic name (nonproprietary): magnesium sulfate in dextrose
Active ingredients: Magnesium sulfate heptahydrate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Baxter Healthcare Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211965
Marketing start: Aug 11, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0338-1709_1fd589e9-dee6-46e8-99f8-810cea9692c3SPL ID 1fd589e9-dee6-46e8-99f8-810cea9692c3SPL set ID 1bbaebd0-3f4c-467d-96fd-69cfad5a3fd3RxCUI 829757UNII SK47B8698T
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338170940 followed by a unit qualifier and the quantity

Package 00338-1709-40. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 30, 2024.

Indications (excerpt from the label)

Magnesium Sulfate in 5% Dextrose Injection is indicated for: • Prevention of eclampsia in patients with preeclampsia • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia Magnesium Sulfate in 5% Dextrose Injection is indicated for (1) : • Prevention of eclampsia in patients with preeclampsia (1) • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)